Skip to main content

and
  1. No Access

    Article

    Chemotherapy of non-small cell lung cancer: Clinical trials at the Memorial Sloan-Kettering Cancer Center

    Bronchogenic carcinoma is one of the most difficult and pressing problems in cancer therapy. Overall survival of 799 primary cases at Memorial Sloan-Kettering Cancer Center was 7.8%, reflecting the advanced na.....

    R. J. Gralla, R. E. Wittes, E. S. Casper, D. P. Kelsen in World Journal of Surgery (1981)